Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Persistence and reappearance of high-risk human papillomavirus after conization.

Gosvig CF, Huusom LD, Andersen KK, Iftner A, Cederkvist L, Svare E, Iftner T, Kjaer SK.

Gynecol Oncol. 2013 Dec;131(3):661-6. doi: 10.1016/j.ygyno.2013.09.002. Epub 2013 Sep 13.

PMID:
24035849
2.

Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3.

Kreimer AR, Katki HA, Schiffman M, Wheeler CM, Castle PE; ASCUS-LSIL Triage Study Group..

Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):11-6.

3.

Prognostic significance of high-risk HPV persistence after laser CO2 conization for high-grade CIN: a prospective clinical study.

Fallani MG, Penna C, Marchionni M, Bussani C, Pieralli A, Andersson KL, Fambrini M.

Eur J Gynaecol Oncol. 2008;29(4):378-82.

PMID:
18714574
4.

The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization.

Park JY, Lee KH, Dong SM, Kang S, Park SY, Seo SS.

Gynecol Oncol. 2008 Mar;108(3):549-54. doi: 10.1016/j.ygyno.2007.11.009. Epub 2008 Jan 4.

PMID:
18177929
5.

PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia.

Fambrini M, Penna C, Pieralli A, Bussani C, Fallani MG, Andersson KL, Scarselli G, Marchionni M.

Gynecol Oncol. 2008 Apr;109(1):59-64. doi: 10.1016/j.ygyno.2007.12.032. Epub 2008 Feb 5.

PMID:
18255129
6.

Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization.

Costa S, De Simone P, Venturoli S, Cricca M, Zerbini ML, Musiani M, Terzano P, Santini D, Cristiani P, Syrjänen S, Syrjänen K.

Gynecol Oncol. 2003 Aug;90(2):358-65.

PMID:
12893200
7.

Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.

Almog B, Gamzu R, Kuperminc MJ, Levin I, Fainaru O, Niv J, Bar-Am A.

Gynecol Oncol. 2003 Mar;88(3):345-50.

PMID:
12648585
8.

Persistent HPV infection after conization in patients with negative margins.

Song SH, Lee JK, Oh MJ, Hur JY, Na JY, Park YK, Saw HS.

Gynecol Oncol. 2006 Jun;101(3):418-22. Epub 2006 Jan 4.

PMID:
16386782
9.

Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment.

Venturoli S, Ambretti S, Cricca M, Leo E, Costa S, Musiani M, Zerbini M.

J Med Virol. 2008 Aug;80(8):1434-40. doi: 10.1002/jmv.21198.

PMID:
18551620
10.
11.

Is therapeutic conization sufficient to eliminate a high-risk HPV infection of the uterine cervix? A clinicopathological analysis.

Bodner K, Bodner-Adler B, Wierrani F, Kimberger O, Denk C, Grünberger W.

Anticancer Res. 2002 Nov-Dec;22(6B):3733-6.

PMID:
12552985
12.

Predictors of absence of cervical intraepithelial neoplasia in the conization specimen.

Rodriguez-Manfredi A, Alonso I, del Pino M, Fusté P, Torné A, Ordi J.

Gynecol Oncol. 2013 Feb;128(2):271-6. doi: 10.1016/j.ygyno.2012.10.020. Epub 2012 Oct 29.

PMID:
23116936
13.

Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix.

Kong TW, Son JH, Chang SJ, Paek J, Lee Y, Ryu HS.

Gynecol Oncol. 2014 Dec;135(3):468-73. doi: 10.1016/j.ygyno.2014.09.022. Epub 2014 Oct 2.

PMID:
25284039
14.

Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway.

Vintermyr OK, Iversen O, Thoresen S, Quint W, Molijn A, de Souza S, Rosillon D, Holl K.

Gynecol Oncol. 2014 May;133(2):159-66. doi: 10.1016/j.ygyno.2014.03.004. Epub 2014 Mar 11.

PMID:
24631451
15.

Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.

Alonso I, Torné A, Puig-Tintoré LM, Esteve R, Quinto L, Campo E, Pahisa J, Ordi J.

Gynecol Oncol. 2006 Nov;103(2):631-6. Epub 2006 Jun 14.

PMID:
16780934
16.

[Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia].

Zhao FH, Hu SY, Wang SM, Chen F, Zhang X, Zhang WH, Pan QJ, Qiao YL.

Zhonghua Yu Fang Yi Xue Za Zhi. 2009 Jul;43(7):565-70. Chinese.

PMID:
19954065
17.

Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up.

Bar-Am A, Gamzu R, Levin I, Fainaru O, Niv J, Almog B.

Gynecol Oncol. 2003 Oct;91(1):149-53.

PMID:
14529675
18.
19.

Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.

Dalstein V, Riethmuller D, Prétet JL, Le Bail Carval K, Sautière JL, Carbillet JP, Kantelip B, Schaal JP, Mougin C.

Int J Cancer. 2003 Sep 1;106(3):396-403.

20.

Supplemental Content

Support Center